Efficacy and safety of different low molecular weight heparins in the treatment of venous thromboembolism

被引：0

作者：

Siragusa, S ^{[1
]}

Cosmi, B ^{[1
]}

Barone, M ^{[1
]}

Beltrametti, C ^{[1
]}

Serafini, S ^{[1
]}

Piovella, F ^{[1
]}

机构：

[1] IRCCS,POLICLIN S MATTEO,MED CLIN 2,THROMBOEMBOLISM UNIT,PAVIA,ITALY

来源：

THROMBOSIS AND HAEMOSTASIS | 1997年

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：P1190 / P1190

页数：1

共 50 条

[41] COMPARISON OF EFFICACY AND SAFETY OF LOW-MOLECULAR-WEIGHT HEPARINS AND UNFRACTIONATED HEPARIN IN INITIAL TREATMENT OF DEEP VENOUS THROMBOSIS - A METAANALYSIS
WESTERMANN, KW
HERZ KREISLAUF, 1994, 26 (11): : 352 - 352
[42] COMPARISON OF EFFICACY AND SAFETY OF LOW-MOLECULAR-WEIGHT HEPARINS AND UNFRACTIONATED HEPARIN IN INITIAL TREATMENT OF DEEP VENOUS THROMBOSIS - A METAANALYSIS
LEIZOROVICZ, A
SIMONNEAU, G
DECOUSUS, H
BOISSEL, JP
BMJ-BRITISH MEDICAL JOURNAL, 1994, 309 (6950): : 299 - 304
[43] Low-molecular-weight heparins for venous thromboembolism: Making an evidence-based treatment choice - Introduction
Haines, ST
PHARMACOTHERAPY, 2001, 21 (06): : 49S - 50S
[44] Prophylaxis and treatment of venous thromboembolism in cancer patients. Clinical value of low-molecular-weight heparins
Kreher, S.
Riess, H.
INTERNIST, 2014, 55 (04): : 448 - +
[45] Low-molecular-weight heparins for venous thromboembolism - Making an evidence-based treatment choice - Discussion
Haines, ST
Pineo, G
Lopez, L
Racine, E
PHARMACOTHERAPY, 2001, 21 (06): : 71S - 72S
[46] Safety and efficacy of bridging with low molecular weight heparins: a systematic review
Eijgenraam, P.
ten Cate, H.
ten Cate-Hoek, A.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 13 - 13
[47] Safety and Efficacy of Direct Oral Anticoagulants vs Low Molecular Weight Heparin for Treatment of Venous Thromboembolism in Patients With Cancer
Singh, Sahib
Tantry, Udaya
Bliden, Kevin
Gurbel, Paul
CIRCULATION, 2023, 148
[48] Outpatient therapy with low molecular weight heparin for treatment of venous thromboembolism: A systematic review of efficacy, safety, and costs.
Segal, JB
Bolger, DT
Jenckes, MW
Tamariz, LJ
Streiff, MB
Eng, J
Krishnan, JA
Bass, EB
JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 : 166 - 166
[49] Safety of heparins for venous thromboembolism prophylaxis
Seale, Paul
Campbell, Gillian
AUSTRALIAN PRESCRIBER, 2010, 33 (06) : 170 - 170
[50] Low-molecular-weight heparins in the prophylaxis and treatment of pulmonary thromboembolism - Response
de la Calzada, CS
REVISTA ESPANOLA DE CARDIOLOGIA, 2001, 54 (09): : 1121 - 1122

← 1 2 3 4 5 →